Difference between revisions of "WSI22-127-Case-2"

From MGH Learn Pathology
Line 25: Line 25:
 
|reasonCode=H&E
 
|reasonCode=H&E
 
|view=show
 
|view=show
|modality=dzi
+
|modality=mrxs
 
}}
 
}}
 
{{Media
 
{{Media
Line 35: Line 35:
 
|reasonCode=BRAF
 
|reasonCode=BRAF
 
|view=show
 
|view=show
|modality=dzi
+
|modality=mrxs
 
}}
 
}}
 
{{Media
 
{{Media
Line 45: Line 45:
 
|reasonCode=H&E
 
|reasonCode=H&E
 
|view=show
 
|view=show
|modality=dzi
+
|modality=mrxs
 
}}
 
}}

Revision as of 08:52, September 16, 2022

WSI22-127-Case-2
30s female with thyroid mass and enlarged bilateral lymph nodes.
Papillary thyroid carcinoma, diffuse sclerosing variant. Follow-up molecular: CCDC6(e1)::RET(e12) fusion.
October 26, 2022 1:15:00 AM